论文部分内容阅读
目的:探讨原发性肝癌患者血清β2-微球蛋白(β2-MG)含量检测的意义。方法:选择急、慢性乙型肝炎、乙肝肝硬化、重型肝炎及原发性肝癌患者,分别检测血清中β2-MG含量。结果:(1)肝癌患者血β2-MG含量比急、慢性乙型肝炎、乙肝肝硬化患者高;(2)随肝癌分期增加,血清β2-MG含量有增加的趋势。结论:血清β2-MG含量的检测,有助于肝癌、肝硬化及肝炎的鉴别诊断。
Objective: To investigate the significance of detection of serum β2-microglobulin (β2-MG) in patients with primary liver cancer. Methods: The patients with acute and chronic hepatitis B, cirrhosis of hepatitis B, severe hepatitis and primary liver cancer were selected to detect the content of β2-MG in serum respectively. Results: (1) The blood β2-MG level in patients with hepatocellular carcinoma was higher than those in acute and chronic hepatitis B and hepatitis B cirrhosis patients. (2) Serum β2-MG content increased with the increase of liver cancer staging. Conclusion: The detection of serum β2-MG content is helpful for the differential diagnosis of liver cancer, liver cirrhosis and hepatitis.